March 18, 2020 / 10:18 PM / 20 days ago

BRIEF-89Bio Qtrly Loss Per Share $2.58

March 18 (Reuters) - 89Bio Inc:

* 89BIO REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

* 89BIO INC - QTRLY LOSS PER SHARE $2.58

* 89BIO - TOPLINE DATA FROM PHASE 1B/2A NONALCOHOLIC STEATOHEPATITIS (NASH) STUDY EXPECTED IN H2 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below